Active Ingredient(s):Sucroferric Oxyhydroxide FDA Approved: * November 27, 2013 Pharm Company: *VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA FRANCE Category:Hyperphosphatemia
Phosphate binders are medications used to reduce the absorption of dietary phosphate; they are taken along with meals and snacks. They are frequently used in people with chronic kidney failure (CKF), who are less able to excrete phosphate, resulting in an elevated serum phosphate.
1 Mechanism of action
2 Medical use
3 Adverse effects
4 Choice of agent
6 External links
6.1 Common Phosphate Binders
Mechanism of action
These agents work by binding to ...
* May have multiple approval dates, manufacturers, or labelers.